Funding search · EIN 366975534 · Dallas, TX
Dr Ralph & Marian Falk Medical Research Tr
A private foundation (files IRS Form 990-PF). Most private foundations do not take unsolicited applications; the route in is usually a program officer.
- 141
- grants reported
- $32.5M
- total given
- 2021–2024
- filing years
- $175,864
- median grant
Based on grants this organization reported to the IRS for tax years 2021–2024. This is what they filed, not a complete record of their giving, and recent years may be incomplete because filings lag.
What they fund
Full IRS filings ↗How this is builtReport an error
Funding pattern
What this funder pays for, at what size, and how to position adjacent work. Read from their filings, with every number checked against the record.
Sign in to analyze this funder’s giving pattern. Free in early access.
Top recipients
Repeat recipients are the strongest signal of whether a funder has an open door or quietly re-funds the same organizations.
- Medical College of Wisconsin6 grants · $2.6M
- Cleveland Clinic Foundation8 grants · $2.5M
- Yale University School of Medicine7 grants · $2.0M
- Indiana University9 grants · $2.0M
- Case Western Reserve University8 grants · $1.9M
- Childrens Hospital Medical Center5 grants · $1.8M
- Regents of University of Michigan6 grants · $1.7M
- University of Cincinnati8 grants · $1.6M
- University of Minnesota9 grants · $1.5M
- Brown University of Providence5 grants · $1.5M
Giving over time
Grant history
The 100 largest of 141 grants.
- $1.2M
Medical College of Wisconsin · Milwaukee, WI · 2021
Research for chronic pain;
- $1.1M
Childrens Hospital Medical Center · Cincinnati, OH · 2021
Research for parkinsons,
- $1.1M
Cleveland Clinic Foundation · Cleveland, OH · 2021
Glioblastoma treatments &
- $1.1M
Yale University School of Medicine · New Haven, CT · 2021
Develope cancer vaccines;
- $869,930
Regents of University of Michigan · Pittsburgh, PA · 2021
Device to predict
- $504,854
Brown University of Providence · Providence, RI · 2022
Anti-malaria drugs targetng
- $497,018
University of Cincinnati · Cleveland, OH · 2023
Inhibitors targeting peanut
- $495,146
Brown University of Providence · Providence, RI · 2023
Anti-malaria drugs targetng
- $460,000
Stanford University · Menlo Park, CA · 2021
Biomarkers for immune
- $445,923
Indiana University · Bloomington, IN · 2022
Targeting peanut-specific
- $400,000
Michigan State University · East Lansing, MI · 2021
Novel rxr agonist for
- $377,004
Medical College of Wisconsin · Milwaukee, WI · 2023
New drugs to treat
- $355,809
Case Western Reserve University · Cleveland, OH · 2024
Immunotherapy for b cell
- $348,252
Yale University - School of Medicine · New Haven, CT · 2024
Making cancer cells look
- $346,469
Medical College of Wisconsin Sen Neuron · Milwaukee, WI · 2022
Development of sensory
- $343,159
Case Western Reserve University · Cleveland, OH · 2023
B cell cancer therapy using
- $340,879
Indiana University · Bloomington, IN · 2024
Pim2 modulator-multiple
- $336,255
Cleveland Clinic Foundation · Cleveland, OH · 2023
Development of new drug for
- $334,583
Medical College of Wisconsin · Milwaukee, WI · 2024
Pain therapy - sensory
- $333,333
Thomas Jefferson University · Philadelphia, PA · 2024
Protacs for targeting brca
- $333,333
Thomas Jefferson University · Philadelphia, PA · 2023
Protacs for targeting brca
- $333,333
Thomas Jefferson University · Philadelphia, PA · 2022
Protacs for targeting brca
- $331,974
Northwestern University · Evanstone, IL · 2022
T cell thearpy for
- $331,873
Cleveland Clinic Foundation · Cleveland, OH · 2024
Development of new drug for
- $330,487
Board Regents of University of Wisconsin · Milwaukee, WI · 2024
Improve diagnosis of breast
- $320,000
Indiana University · Detroit, MI · 2021
Targeting peanut-specific
- $318,948
Medical College of Wisconsin · Milwaukee, WI · 2023
Development of sensory
- $315,981
Medical College of Wisconsin · Milwaukee, WI · 2024
New drugs to treat
- $308,897
Universityof Minnesota · Minneapolis, MN · 2024
T3 therapy - heart failure
- $301,032
Case Western Reserve University · Cleveland, OH · 2022
B cell cancer therapy using
- $284,681
University of Minnesota · Minneapolis, MN · 2024
Optimized mechanism based
- $268,735
University of Chicago · Chicago, IL · 2024
Metastic lung cancer phase
- $260,000
Case Western Reserve University · Cleveland, OH · 2021
Immunotherapy for b cell
- $257,044
Purdue University · West Lafayette, IN · 2024
Advancing micro rnas as
- $235,086
Universityof Minnesota · Minneapolis, MN · 2023
Thyroid hormone
- $211,322
University of Cincinnati · Cleveland, OH · 2022
Studies for repurposing
- $210,398
Northwestern University · Evanston, IL · 2024
Therapy for chronic kidney
- $208,319
University of Iowa · Iowa City, IA · 2024
Vascular health targeting
- $204,619
University of Cincinnati · Cleveland, OH · 2022
Targeting sexual cycle of
- $203,837
University of Minnesota · Minneapolis, MN · 2024
Systemic bacteremia - host
- $200,685
University of Chicago · Chicago, IL · 2023
Tumor anueploidy -
- $200,000
Childrens Hospital Medical Center · Cincinnati, OH · 2022
Lupus nephritis biomarkers
- $200,000
Cleveland Clinic Foundation · Cleveland, OH · 2022
New weapons to fight
- $200,000
Regents of University of Michigan · Ann Arbor, MI · 2022
Device to predict
- $200,000
Yale University School of Medicine · New Haven, CT · 2022
Targeted degredation of
- $200,000
Kumc Ri · Kansas City, KS · 2021
Eulicidating the role of
- $200,000
Northwestern University · Evanstone, IL · 2021
Neoantigen inducers as
- $200,000
Ohio State University · Columbus, OH · 2021
Optimizingn btk inhibitor
- $200,000
Regents of the Univ of Minnesota · Minneapolis, MN · 2021
Electrical brain circuit
- $200,000
Rush University Medical Center · Chicago, IL · 2021
Anti-hiv antibodies to
- $200,000
University of Chicago · Chicago, IL · 2021
Instatistical design of
- $200,000
University of Iowa Research Foundation · Iowa City, IA · 2021
Piezoelectric immunosensor
- $197,879
Ohio State University · Columbus, OH · 2023
Develop new therapy for
- $196,613
Thomas Jefferson University · Philadelphia, PA · 2022
Chemokine antagonist for
- $190,000
Childrens Hospital Medical Center · Cincinnati, OH · 2023
Lupus nephritis biomarkers
- $190,000
Cleveland Clinic Foundation · Cleveland, OH · 2023
New weapons to fight
- $190,000
Regents of University of Michigan · Ann Arbor, MI · 2023
Device to predict
- $190,000
Yale University School of Medicine · New Haven, CT · 2023
Targeted degredation of
- $190,000
Board Regents of University of Wisconsin · Milwaukee, WI · 2022
Nanoparticles target
- $190,000
Childrens Hospital Medical Center · Cincinnati, OH · 2022
Develop human liver
- $190,000
Stanford University - Development Services · Redwood City, CA · 2022
Novel therapies - major
- $187,210
State University of Iowa · Iowa City, IA · 2023
Improve hypoxic tumor mgmt
- $186,955
Cleveland Clinic Foundation · Cleveland, OH · 2024
Treatment of complex
- $181,905
Mayo Clinic · Rochester, MN · 2023
In vivo generation of car t
- $179,775
Indiana University · Bloomington, IN · 2023
Traumatic brain injury
- $178,604
Ohio State University · Columbus, OH · 2024
Melanoma onset & recurrence
- $177,796
Rehabilitation Institute of Chicago · Chicago, IL · 2023
Repurpose 5-azacytidine -
- $177,271
Indiana University · Bloomington, IN · 2023
Novel minimally invasive
- $176,327
University of Minnesota · Minneapolis, MN · 2024
Develop il-15 - malaria
- $176,215
Stanford University · Stanford, CA · 2023
Metabolic pausing - organ
- $175,864
Shirley Ryan Ability Lab · Chicago, IL · 2024
Restore diaphragm - nerve
- $175,575
Mayo Clinic · Rochester, MN · 2024
Cd-19 targeted car-msc19 in
- $175,216
Washington University · St Louis, MO · 2023
Zika virus genetic arming-
- $175,188
Yale University School of Medicine · New Haven, CT · 2022
Develop phage therapy to
- $175,000
Brown University of Providence · Providence, RI · 2024
Repurposing clopidogrel to
- $175,000
Case Western Reserve University · Cleveland, OH · 2024
Pharma strategy to treat
- $175,000
Loyola University of Chicago · Chicago, IL · 2024
Inhibitors for triple
- $175,000
Michigan State University · East Lansing, MI · 2024
Develop new odc inhibitors
- $175,000
Regents of University of Michigan · Ann Arbor, MI · 2024
Neuro-cardiac mechanisms of
- $175,000
Regents of University of Michigan · Ann Arbor, MI · 2024
Antibody cns delivery and
- $175,000
University of Cincinnati · Cleveland, OH · 2024
Develop improved method of
- $175,000
Washington University · St Louis, MO · 2024
Stem cell derived islets
- $175,000
Board Regents of University of Wisconsin · Milwaukee, WI · 2023
Diabetes stem cell cure -
- $175,000
Brown University of Providence · Providence, RI · 2023
Repurposing clopidogrel to
- $175,000
Case Western Reserve University · Cleveland, OH · 2023
Blocking peptide treatment
- $175,000
Michigan State University · East Lansing, MI · 2023
Develop new odc inhibitors
- $175,000
University of Chicago · Chicago, IL · 2023
Development of syngap1
- $175,000
University of Cincinnati · Cleveland, OH · 2023
Develop improved method of
- $175,000
Board Regents of University of Wisconsin · Milwaukee, WI · 2022
Diabetes stem cell cure -
- $175,000
Case Western Reserve University · Cleveland, OH · 2022
Blocking peptide treatment
- $175,000
University of Chicago · Chicago, IL · 2022
Development of syngap1
- $174,784
Washington University · St Louis, MO · 2022
Zika virus genetic arming-
- $174,425
Mayo Clinic · Rochester, MN · 2023
Cd-19 targeted car-msc19 in
- $173,839
University of Minnesota · Minneapolis, MN · 2024
Sound waves assessment via
- $173,785
Stanford University - Development Services · Redwood City, CA · 2022
Metabolic pausing - organ
- $173,769
Children'S Hospital Medical Center · Cincinnati, OH · 2024
Autoimmune arthritis
- $173,717
Washington University · St Louis, MO · 2024
Vagus nerve stimulation -
- $173,673
University of Minnesota · Minneapolis, MN · 2023
Develop il-15 - malaria
- $173,096
Brown University of Providence · Providence, RI · 2024
Gene therapy for
- $173,017
Yale University School of Medicine · New Haven, CT · 2023
Develop phage therapy to
Grants already paid are the record; PaperOrbit reads your paper and finds the funders whose record matches it — then explains why.
Search funders like this oneSource: IRS Form 990-PF, Part XV, as filed by the foundation. These are grants already paid — a record of what this funder backs, not an open call.

